nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—AKR1B10—melanoma	0.0958	0.107	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—MYO7A—melanoma	0.083	0.0929	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—CUBN—melanoma	0.0702	0.0785	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—AKR1B10—melanoma	0.0489	0.0548	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.0198	0.0222	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—ALB—melanoma	0.0183	0.0205	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—PRKCA—melanoma	0.0161	0.0181	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.012	0.0134	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MYO7A—melanoma	0.0105	0.0118	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.01	0.0112	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.00938	0.0105	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HS3ST5—melanoma	0.00897	0.01	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ACER3—melanoma	0.00883	0.00989	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—UGT2B10—melanoma	0.00808	0.00904	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00797	0.00893	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HS3ST5—melanoma	0.00751	0.00841	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—DRAP1—melanoma	0.00738	0.00827	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MYO7A—melanoma	0.00738	0.00827	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—TRRAP—melanoma	0.00639	0.00715	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CUL3—melanoma	0.00639	0.00715	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TAS2R60—melanoma	0.00628	0.00703	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKR1B10—melanoma	0.00621	0.00696	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.00604	0.00677	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PLCB4—melanoma	0.00569	0.00637	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—FASN—melanoma	0.00558	0.00625	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—LUM—melanoma	0.00554	0.0062	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HPSE—melanoma	0.00543	0.00608	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC6A11—melanoma	0.00535	0.00599	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIP4K2A—melanoma	0.00535	0.00599	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CUBN—melanoma	0.00533	0.00597	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTAP—melanoma	0.0052	0.00583	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CSPG4—melanoma	0.00515	0.00577	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.00509	0.00569	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—RPS3—melanoma	0.00507	0.00567	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—SKI—melanoma	0.00499	0.00558	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PLCB4—melanoma	0.00476	0.00533	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL1—melanoma	0.00476	0.00533	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—LUM—melanoma	0.00464	0.00519	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PHGDH—melanoma	0.00464	0.00519	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—HPSE—melanoma	0.00455	0.00509	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TRRAP—melanoma	0.00447	0.00501	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CUL3—melanoma	0.00447	0.00501	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CUBN—melanoma	0.00447	0.005	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKR1B10—melanoma	0.00435	0.00487	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SDHD—melanoma	0.00431	0.00483	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—BSG—melanoma	0.00431	0.00483	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CSPG4—melanoma	0.00431	0.00483	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GPAM—melanoma	0.00418	0.00468	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HDAC6—melanoma	0.00412	0.00461	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—F2RL1—melanoma	0.00405	0.00453	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Vemurafenib—melanoma	0.00402	0.0376	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—NPPA—melanoma	0.0039	0.00437	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—VCAN—melanoma	0.00381	0.00426	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRM3—melanoma	0.0038	0.00426	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—WNT5A—melanoma	0.00378	0.00423	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KISS1—melanoma	0.00361	0.00404	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PLA2G6—melanoma	0.00355	0.00398	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SKI—melanoma	0.00349	0.00391	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCR1—melanoma	0.00349	0.00391	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MC1R—melanoma	0.00344	0.00385	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GRM1—melanoma	0.0033	0.00369	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCR7—melanoma	0.0033	0.00369	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Vemurafenib—melanoma	0.00322	0.0301	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SUFU—melanoma	0.00321	0.0036	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—VCAN—melanoma	0.00319	0.00357	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—GAB2—melanoma	0.00303	0.0034	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.00302	0.00338	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RHOB—melanoma	0.003	0.00336	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—BCL2L11—melanoma	0.003	0.00336	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FASN—melanoma	0.00297	0.00333	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.00291	0.00326	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HDAC6—melanoma	0.00288	0.00323	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CXCR4—melanoma	0.00285	0.00319	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HDAC2—melanoma	0.00285	0.00319	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FOXO4—melanoma	0.00285	0.00319	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Vemurafenib—melanoma	0.00285	0.0267	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Vemurafenib—melanoma	0.00283	0.0265	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Vemurafenib—melanoma	0.00283	0.0265	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CD44—melanoma	0.00282	0.00316	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCR2—melanoma	0.00273	0.00306	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP17A1—melanoma	0.00269	0.00301	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RAC2—melanoma	0.00269	0.00301	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.00265	0.00297	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—WNT5A—melanoma	0.00265	0.00296	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFC—melanoma	0.00265	0.00296	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ALB—melanoma	0.00262	0.00293	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT3—melanoma	0.0026	0.00292	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GNA11—melanoma	0.00254	0.00285	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—FASN—melanoma	0.00249	0.00278	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—SLC5A5—melanoma	0.00245	0.00274	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CD44—melanoma	0.00236	0.00265	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GNAQ—melanoma	0.00236	0.00265	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Vemurafenib—melanoma	0.00235	0.022	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—F2R—melanoma	0.00232	0.0026	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.00231	0.00259	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ERBB4—melanoma	0.0023	0.00258	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.00229	0.00257	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN2B—melanoma	0.00228	0.00255	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP1B1—melanoma	0.00227	0.00254	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EDNRB—melanoma	0.00225	0.00252	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Vemurafenib—melanoma	0.00224	0.021	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CD86—melanoma	0.0022	0.00247	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTK2B—melanoma	0.00218	0.00245	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Vemurafenib—melanoma	0.00217	0.0203	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—FGF1—melanoma	0.00214	0.00239	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GAB2—melanoma	0.00213	0.00238	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GNA11—melanoma	0.00213	0.00238	CbGpPWpGaD
Glycerol Phenylbutyrate—Malnutrition—Carmustine—melanoma	0.00212	0.0199	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FLT1—melanoma	0.00212	0.00237	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Vemurafenib—melanoma	0.00209	0.0195	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Docetaxel—melanoma	0.00207	0.0194	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PDGFRA—melanoma	0.00207	0.00232	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Vemurafenib—melanoma	0.00207	0.0194	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Vemurafenib—melanoma	0.00207	0.0193	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Vemurafenib—melanoma	0.00205	0.0192	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Temozolomide—melanoma	0.00205	0.0192	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PRKCA—melanoma	0.00205	0.0023	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—ERCC2—melanoma	0.00203	0.00228	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MAP2K2—melanoma	0.002	0.00224	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.002	0.00224	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HDAC2—melanoma	0.002	0.00224	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCR4—melanoma	0.002	0.00224	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FOXO4—melanoma	0.002	0.00224	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—GNAQ—melanoma	0.00198	0.00221	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Vemurafenib—melanoma	0.00195	0.0182	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—TERT—melanoma	0.00191	0.00213	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HLA-A—melanoma	0.00191	0.00213	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—RAC1—melanoma	0.0019	0.00213	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCB1—melanoma	0.00187	0.00209	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SYK—melanoma	0.00186	0.00208	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NGFR—melanoma	0.00182	0.00204	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT3—melanoma	0.00182	0.00204	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ITGAV—melanoma	0.00182	0.00204	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—HIF1A—melanoma	0.00182	0.00204	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Bleomycin—melanoma	0.00173	0.0162	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PRKCA—melanoma	0.00172	0.00192	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ERCC2—melanoma	0.0017	0.00191	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SOCS1—melanoma	0.00169	0.00189	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—S100B—melanoma	0.00168	0.00189	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS2—melanoma	0.00166	0.00186	CbGpPWpGaD
Glycerol Phenylbutyrate—Nervous system disorder—Temozolomide—melanoma	0.00164	0.0154	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—NOTCH1—melanoma	0.00164	0.00184	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Dactinomycin—melanoma	0.00161	0.0151	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ERBB4—melanoma	0.00161	0.0018	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CD80—melanoma	0.00161	0.0018	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APC—melanoma	0.00161	0.0018	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—KIT—melanoma	0.00161	0.0018	CbGpPWpGaD
Glycerol Phenylbutyrate—Fatigue—Dactinomycin—melanoma	0.0016	0.015	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN2B—melanoma	0.0016	0.00179	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EGF—melanoma	0.00159	0.00178	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CD86—melanoma	0.00154	0.00173	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EDN1—melanoma	0.00153	0.00172	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Dactinomycin—melanoma	0.00152	0.0142	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—BRAF—melanoma	0.00151	0.00169	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Carmustine—melanoma	0.00151	0.0141	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CSF2—melanoma	0.0015	0.00168	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGF1—melanoma	0.0015	0.00168	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Carmustine—melanoma	0.0015	0.014	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Temozolomide—melanoma	0.00148	0.0138	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—E2F1—melanoma	0.00147	0.00164	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Dactinomycin—melanoma	0.00146	0.0137	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Temozolomide—melanoma	0.00146	0.0136	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PDGFRA—melanoma	0.00145	0.00162	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Temozolomide—melanoma	0.00145	0.0135	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Temozolomide—melanoma	0.00144	0.0135	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ITGB3—melanoma	0.00144	0.00161	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PRKCA—melanoma	0.00144	0.00161	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Bleomycin—melanoma	0.00143	0.0133	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—MAP2K1—melanoma	0.00142	0.00159	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Carmustine—melanoma	0.00142	0.0133	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CD—melanoma	0.00141	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.00141	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SPP1—melanoma	0.00141	0.00158	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAP2K2—melanoma	0.0014	0.00157	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Carmustine—melanoma	0.00137	0.0128	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Temozolomide—melanoma	0.00137	0.0128	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Docetaxel—melanoma	0.00137	0.0128	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—FGF2—melanoma	0.00135	0.00151	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CG—melanoma	0.00134	0.00151	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TERT—melanoma	0.00133	0.00149	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RAC1—melanoma	0.00133	0.00149	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Dactinomycin—melanoma	0.00133	0.0124	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Temozolomide—melanoma	0.00132	0.0124	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PPARG—melanoma	0.0013	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HIF1A—melanoma	0.00128	0.00143	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Dactinomycin—melanoma	0.00127	0.0119	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—MDM2—melanoma	0.00126	0.00142	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Bleomycin—melanoma	0.00126	0.0118	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Bleomycin—melanoma	0.00125	0.0117	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Bleomycin—melanoma	0.00125	0.0117	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—ERBB2—melanoma	0.00125	0.0014	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Carmustine—melanoma	0.00124	0.0116	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CB—melanoma	0.00123	0.00138	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CD4—melanoma	0.00123	0.00137	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KDR—melanoma	0.00122	0.00137	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTGS2—melanoma	0.00122	0.00136	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Temozolomide—melanoma	0.0012	0.0113	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Carmustine—melanoma	0.00119	0.0111	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CD—melanoma	0.00118	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Bleomycin—melanoma	0.00118	0.011	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Dactinomycin—melanoma	0.00118	0.011	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FN1—melanoma	0.00117	0.00132	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Dactinomycin—melanoma	0.00117	0.0109	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ALB—melanoma	0.00117	0.00131	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN1B—melanoma	0.00115	0.00129	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOTCH1—melanoma	0.00115	0.00129	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Carmustine—melanoma	0.00115	0.0107	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Temozolomide—melanoma	0.00115	0.0107	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CD80—melanoma	0.00113	0.00126	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KIT—melanoma	0.00112	0.00126	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CG—melanoma	0.00112	0.00126	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APC—melanoma	0.00112	0.00126	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EGF—melanoma	0.00111	0.00124	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Temozolomide—melanoma	0.00111	0.0104	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Carmustine—melanoma	0.0011	0.0103	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Dactinomycin—melanoma	0.0011	0.0103	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Carmustine—melanoma	0.00109	0.0102	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Docetaxel—melanoma	0.00109	0.0102	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Carmustine—melanoma	0.00109	0.0102	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CTNNB1—melanoma	0.00109	0.00122	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Carmustine—melanoma	0.00109	0.0102	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Temozolomide—melanoma	0.00107	0.00997	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN1A—melanoma	0.00107	0.00119	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTEN—melanoma	0.00106	0.00119	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—BRAF—melanoma	0.00106	0.00118	CbGpPWpGaD
Glycerol Phenylbutyrate—Rash—Temozolomide—melanoma	0.00106	0.00989	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Temozolomide—melanoma	0.00106	0.00988	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Temozolomide—melanoma	0.00105	0.00983	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CB—melanoma	0.00103	0.00115	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Carmustine—melanoma	0.00103	0.00964	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IGF1—melanoma	0.00103	0.00115	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTGS2—melanoma	0.00102	0.00114	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Temozolomide—melanoma	0.000995	0.00932	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAP2K1—melanoma	0.000995	0.00111	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CD—melanoma	0.000988	0.00111	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Docetaxel—melanoma	0.000981	0.00918	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Docetaxel—melanoma	0.000969	0.00907	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Docetaxel—melanoma	0.000962	0.00901	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Docetaxel—melanoma	0.000961	0.00899	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—STAT3—melanoma	0.000951	0.00106	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NRAS—melanoma	0.000948	0.00106	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FGF2—melanoma	0.000946	0.00106	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Docetaxel—melanoma	0.000911	0.00853	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—MAPK3—melanoma	0.000908	0.00102	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTEN—melanoma	0.00089	0.000997	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MDM2—melanoma	0.000886	0.000991	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MYC—melanoma	0.000884	0.000989	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Docetaxel—melanoma	0.000881	0.00825	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—ERBB2—melanoma	0.000873	0.000977	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MAPK1—melanoma	0.000864	0.000968	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—EGFR—melanoma	0.000864	0.000968	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CB—melanoma	0.000862	0.000965	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CXCL8—melanoma	0.000828	0.000927	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—KRAS—melanoma	0.000816	0.000914	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN1B—melanoma	0.000809	0.000905	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Docetaxel—melanoma	0.0008	0.00748	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CASP3—melanoma	0.000792	0.000887	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL2—melanoma	0.000791	0.000886	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CCND1—melanoma	0.000771	0.000864	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CTNNB1—melanoma	0.000764	0.000855	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Docetaxel—melanoma	0.000763	0.00714	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—PIK3CA—melanoma	0.00075	0.00084	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP9—melanoma	0.000749	0.000838	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN1A—melanoma	0.000746	0.000835	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTEN—melanoma	0.000744	0.000834	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NFKB1—melanoma	0.000741	0.00083	CbGpPWpGaD
Glycerol Phenylbutyrate—Dizziness—Docetaxel—melanoma	0.000737	0.0069	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Docetaxel—melanoma	0.000709	0.00663	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Docetaxel—melanoma	0.000703	0.00658	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Docetaxel—melanoma	0.000702	0.00657	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Docetaxel—melanoma	0.000698	0.00654	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—HRAS—melanoma	0.000694	0.000777	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFA—melanoma	0.000672	0.000753	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—STAT3—melanoma	0.000666	0.000745	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NRAS—melanoma	0.000664	0.000744	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—IL6—melanoma	0.000664	0.000744	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Docetaxel—melanoma	0.000662	0.0062	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAPK3—melanoma	0.000636	0.000712	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PIK3CA—melanoma	0.000628	0.000703	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MYC—melanoma	0.000619	0.000693	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—AKT1—melanoma	0.000613	0.000686	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MAPK1—melanoma	0.000605	0.000678	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EGFR—melanoma	0.000605	0.000678	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—KRAS—melanoma	0.000572	0.00064	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PIK3CA—melanoma	0.000525	0.000588	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—AKT1—melanoma	0.000513	0.000574	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TP53—melanoma	0.000508	0.000569	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HRAS—melanoma	0.000486	0.000544	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—IL6—melanoma	0.000465	0.000521	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—AKT1—melanoma	0.000429	0.00048	CbGpPWpGaD
